glp-1/gcgr dual agonist Effects, working principles and target tissues of agonists Schematic illustration of monoagonists, dual
Description
GLP-1RAs contribute to improved glycemic control by lowering glycated hemoglobin (HbA1c) and promoting weight loss without causing hypoglycemia, a notable advantage over sulfonylureas and meglitinides

L., Ye, X., Islas, M

Tirzepatides renal outcomes trial is ongoing

The neurons in these areas that express the GLP-1 receptor interact with GLP-1 analogs, indirectly influencing central circuits

And another GLP-1 pill for weight loss is also on its way: Eli Lilly, maker of Zepbound and Mounjaro and a Novo Nordisk competitor, is developing a tablet called orforglipron, which is expected to receive FDA approval this spring.

No, routine thyroid screening with calcitonin blood tests or ultrasound scans is not recommended for patients taking GLP-1 medications
